These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2475407)

  • 21. Factor VIII immunological assay. An evaluation of several methods using whole plasma.
    Girolami A; Sticchi A; Barbui T; Bareggi G
    Blut; 1974 Nov; 29(5):309-16. PubMed ID: 4214574
    [No Abstract]   [Full Text] [Related]  

  • 22. Factor VIII related activities in concentrates.
    Nilsson IM; Borge L; Gunnarsson M; Kristoffersson AC
    Scand J Haematol Suppl; 1984; 41():157-72. PubMed ID: 6440282
    [No Abstract]   [Full Text] [Related]  

  • 23. Study of congenital VIII complex deficiency syndrome: use of enzyme conjugated antibody.
    Han P; Teo SH; Wong HB
    J Singapore Paediatr Soc; 1987; 29(1):44-7. PubMed ID: 3121916
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand's disease platelets.
    Shearn SA; Giddings JC; Peake IR; Bloom AL
    Thromb Res; 1974 Nov; 5(5):585-99. PubMed ID: 4614489
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factor VIII (von Willebrand antigen) in patients with acquired thrombocytopathies].
    Genova V; Baleva M; Nikolov K
    Vutr Boles; 1987; 26(2):82-5. PubMed ID: 3111097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems.
    Muntean W; Hathaway WE; Montgomery RR
    Br J Haematol; 1982 Aug; 51(4):649-58. PubMed ID: 6809034
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of factor VIII-related antigen using commercial antisera.
    Chediak J; Maxey B; Telfer M
    Am J Clin Pathol; 1977 May; 67(5):462-9. PubMed ID: 404869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 33. [The factor VIII complex: hemophilia A and von Willebrand disease (author's transl)].
    Tobelem G; Rothschild C
    Ann Pediatr (Paris); 1982 Feb; 29(2):95-9. PubMed ID: 6800297
    [No Abstract]   [Full Text] [Related]  

  • 34. [Processing data for predicting hemophilia transmission].
    Sikorová J; Zvárová J; Paluska E; Vorlová Z
    Vnitr Lek; 1984 Aug; 30(8):764-70. PubMed ID: 6438902
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quantitative determination of factor VIII antigen with an enzyme immunoassay].
    Schössler W; Stepanauskas M; Dittrich C; von Chr Eichhorn M
    Acta Biol Med Ger; 1982; 41(7-8):695-703. PubMed ID: 6815947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic heterogeneity of hemophilia.
    Colman RW
    N Engl J Med; 1973 Feb; 288(7):369-70. PubMed ID: 4539474
    [No Abstract]   [Full Text] [Related]  

  • 38. [Enzyme immunoassay of factor VIII-related antigen with observation in patients with von Willebrand's disease and hemophilia A (author's transl)].
    Okuda T; Masuyama H; Tanigawa T; Narihiro N; Fujimura Y; Takase T; Mikami S; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1980 Jul; 21(7):946-52. PubMed ID: 6775115
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitation of factor VIII related antigen (FVIIIRAG) using a laser nephelometer.
    Giddings JC; Evans DJ; Bloom AL
    Thromb Res; 1979; 15(5-6):847-55. PubMed ID: 315111
    [No Abstract]   [Full Text] [Related]  

  • 40. [Laser nephelometry of factor VIII - related antigen : for assay (author's transl)].
    Okuda T; Masuyama H; Matsuoka H; Tsukada S; Tanigawa T
    Rinsho Byori; 1981 Aug; 29(8):849-53. PubMed ID: 6796726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.